, Tracking Stock Market Picks
Enter Symbol:
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

up 545.63 %

Cubist Pharmaceuticals, Inc. (CBST) rated Buy with price target $68 by Wedbush Morgan

Posted on: Friday,  Mar 20, 2009  1:25 PM ET by Wedbush Morgan

Wedbush Morgan rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 03/20/2009, when the stock price was $15.69. Since
then, Cubist Pharmaceuticals, Inc. has gained 545.63% as of 01/16/2015's recent price of $101.30.
If you would have followed this Wedbush Morgan's recommendation on CBST, you would have gained 545.63% of your investment in 2128 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2009 1:25 PM Buy
15.69 68.00
as of 12/31/2009
1 Week up  16.64 %
1 Month up  33.15 %
3 Months up  9.95 %
1 YTD up  41.55 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy